Literature DB >> 11916172

Association of the CTLA4 3' untranslated region polymorphism with the susceptibility to rheumatoid arthritis.

M R Rodríguez1, A Núñez-Roldán, F Aguilar, A Valenzuela, A García, M F González-Escribano.   

Abstract

Cytotoxic T-lymphocyte antigen 4 (CTLA4) gene polymorphism located in the 3' untranslated region (UTR) was investigated in 141 Spanish patients (38 men and 103 women) with rheumatoid arthritis (RA) and in 194 ethnically-matched healthy controls. Twenty alleles having different numbers of (AT) repeats (from 7 to 32) were found in this population. (AT)7 and (AT)16 were the most frequent alleles, and accounted for almost two-thirds of the allelic frequency in the control population. Consequently, alleles were assigned as L (large: 16 or more AT repeats) or S (short: less than 16 AT repeats). When the L/S distribution in patients and controls were compared, an increase of L alleles was observed among patients (49.9% vs. 39.7%; p = 0.02; p(c) = 0.04, odds ratio [OR] = 1.46; 95% confidence interval [CI], 1.06-2.01). Hence, the frequency of S alleles was decreased among patients (51.1% vs. 60.3%; p = 0.02; p(c) = 0.04; OR = 0.69; 95%CI, 0.50-0.95). Moreover, a statistically significant decrease in the frequency of S/S individuals was observed among RA patients (27.7% versus 40.7%; p = 0.01; p(c) = 0.03; OR = 0.56; 95%CI, 0.34-0.91). These differences were irrespective of the HLA "shared epitope" (SE) status, and were observed similarly among SE+ as well as among SE- patients. After combining these data with other reported previously by us, from studies of CTLA4 49 (A/G) and -318 (C/T) polymorphisms, we conclude that the strongest association between CTLA4 gene polymorphisms and RA susceptibility occurs with the 3' UTR polymorphism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916172     DOI: 10.1016/s0198-8859(01)00358-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

1.  Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese.

Authors:  Haruhisa Machida; Kazuhiro Tsukamoto; Chun-Yang Wen; Yukiko Narumi; Saburou Shikuwa; Hajime Isomoto; Fuminao Takeshima; Yohei Mizuta; Norio Niikawa; Ikuo Murata; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

2.  Microsatellite GT polymorphism in intron 2 of human Toll-like receptor (TLR) 2 gene and susceptibility to periodontitis.

Authors:  Matthias Folwaczny; Jürgen Glas; Laurean Tonenchi; Helga-Paula Török
Journal:  Clin Oral Investig       Date:  2010-03-16       Impact factor: 3.573

3.  Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.

Authors:  Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux
Journal:  Am J Hum Genet       Date:  2005-11-01       Impact factor: 11.025

4.  CTLA4 is differentially associated with autoimmune diseases in the Dutch population.

Authors:  Alexandra Zhernakova; Peter Eerligh; Pilar Barrera; Joanna Z Wesoly; Joanna Z Weseloy; Tom W J Huizinga; Bart O Roep; Cisca Wijmenga; Bobby P C Koeleman
Journal:  Hum Genet       Date:  2005-07-16       Impact factor: 4.132

5.  Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis.

Authors:  B M Spriewald; O Witzke; R Wassmuth; R R Wenzel; M-L Arnold; T Philipp; J R Kalden
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-12-18       Impact factor: 2.316

7.  Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis.

Authors:  F B S Briggs; P P Ramsay; E Madden; J M Norris; V M Holers; T R Mikuls; T Sokka; M F Seldin; P K Gregersen; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-21       Impact factor: 2.676

8.  Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Authors:  E W Karlson; L B Chibnik; J Cui; R M Plenge; R J Glass; N E Maher; A Parker; R Roubenoff; E Izmailova; J S Coblyn; M E Weinblatt; N A Shadick
Journal:  Ann Rheum Dis       Date:  2007-07-31       Impact factor: 19.103

9.  Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Pharmgenomics Pers Med       Date:  2010-03-30

Review 10.  Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.

Authors:  Monika C Brunner-Weinzierl; Holger Hoff; Gerd-R Burmester
Journal:  Arthritis Res Ther       Date:  2004-03-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.